SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-23-054422
Filing Date
2023-05-01
Accepted
2023-05-01 16:34:09
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-3 tm2313982-1_f3.htm F-3 455117
2 EXHIBIT 5.1 tm2313982d2_ex5-1.htm EX-5.1 16606
3 EXHIBIT 23.2 tm2313982d2_ex23-2.htm EX-23.2 3641
4 EXHIBIT 23.3 tm2313982d2_ex23-3.htm EX-23.3 2507
5 EXHIBIT 23.4 tm2313982d2_ex23-4.htm EX-23.4 6220
6 EX-FILING FEES tm2313982d2_ex-filingfees.htm EX-FILING FEES 49815
7 GRAPHIC lg_belite-4clr.jpg GRAPHIC 13114
8 GRAPHIC tm2313982d2_ex23-3img001.jpg GRAPHIC 6382
9 GRAPHIC fc_belite-bwlr.jpg GRAPHIC 126120
10 GRAPHIC tm2313982d2_ex23-2img001.jpg GRAPHIC 19937
11 GRAPHIC tm2313982d2_ex23-2img002.jpg GRAPHIC 38284
  Complete submission text file 0001104659-23-054422.txt   802614
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-271549 | Film No.: 23874296
SIC: 2834 Pharmaceutical Preparations